Application of CRISPR-Cas9 gene editing for congenital heart disease

Volume: 64, Issue: 6, Pages: 269 - 279
Published: Jun 15, 2021
Abstract
Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR-Cas9) is an ancient prokaryotic defense system that precisely cuts foreign genomic DNA under the control of a small number of guide RNAs. The CRISPR-Cas9 system facilitates efficient double-stranded DNA cleavage that has been recently adopted for genome editing to create or correct inherited genetic mutations causing disease. Congenital heart...
Paper Details
Title
Application of CRISPR-Cas9 gene editing for congenital heart disease
Published Date
Jun 15, 2021
Volume
64
Issue
6
Pages
269 - 279
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.